Conservest Capital Advisors Inc. Acquires 912 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Conservest Capital Advisors Inc. lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 38,991 shares of the exchange traded fund’s stock after buying an additional 912 shares during the period. SPDR S&P Biotech ETF comprises 0.4% of Conservest Capital Advisors Inc.’s holdings, making the stock its 29th largest holding. Conservest Capital Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,482,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. EPG Wealth Management LLC grew its holdings in SPDR S&P Biotech ETF by 152.7% during the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after purchasing an additional 278 shares during the last quarter. Tennessee Valley Asset Management Partners bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $44,000. Wetzel Investment Advisors Inc. bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $45,000. Sheets Smith Wealth Management bought a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at about $55,000. Finally, Life Planning Partners Inc bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $64,000.

SPDR S&P Biotech ETF Stock Up 1.5 %

NYSEARCA:XBI traded up $1.27 during mid-day trading on Friday, hitting $83.49. 10,452,779 shares of the stock traded hands, compared to its average volume of 11,723,970. The stock has a market capitalization of $6.49 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The firm’s 50 day moving average is $92.69 and its two-hundred day moving average is $84.72.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.